Deep Blue Medical Advances
PrivateLast Round
Series A
Apr 21, 2026
Total Funding Raised
$21.82M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Deep Blue Medical Advances operates in Healthcare & Life Sciences and is based in Durham, North Carolina. Its latest recorded funding round was a Series A round in April 2026.
Deep Blue Medical Advances is a medical device company that develops and commercializes surgical products for hernia repair and other soft tissue surgeries.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Deep Blue Medical Advances Comparables
Compare Deep Blue Medical Advances with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Novus Scientific | 84% | |
| Ariste Medical | 83% | |
| TELA Bio, Inc. | 79% |
For institutional investors. Book with your work email.
Deep Blue Medical Advances Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 21, 2026 | ||||
| VC Round | Sep 5, 2024 | ||||
| Series A Extension | Jun 28, 2022 | ||||
| Series A | Feb 3, 2021 | ||||
| Debt | Jan 28, 2021 | ||||
Debt | Aug 8, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Deep Blue Medical Advances Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BayMed Venture Partners | Series A Extension |
| Triangle Angel Partners | Series A |
| North Carolina Biotechnology Center | Debt, Grant |
| Wolfpack Investor Network | VC Round |
| Band of Angels | Series A |
| Harbright Ventures | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 21, 2026
Raised $6M in Series A funding.
- Apr 21, 2026
Preparing for commercial launch of flagship soft tissue repair platform.
For institutional investors. Book with your work email.
Deep Blue Medical Advances Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Deep Blue Medical Advances's valuation, stock price, and market status.
Is Deep Blue Medical Advances a public or private company?
Deep Blue Medical Advances is a private company.
What is the current stock price of Deep Blue Medical Advances?
Deep Blue Medical Advances is a private company, so its shares have no public market price. Caplight tracks Deep Blue Medical Advances's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Deep Blue Medical Advances worth (valuation)?
Valuation information for Deep Blue Medical Advances is not publicly available.
Can I buy Deep Blue Medical Advances stock?
Deep Blue Medical Advances shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Deep Blue Medical Advances's last funding round?
Deep Blue Medical Advances's most recent funding round was Series A on April 21, 2026.
Who are the main investors in Deep Blue Medical Advances?
Key investors in Deep Blue Medical Advances include BayMed Venture Partners.
Will Deep Blue Medical Advances IPO soon?
No public IPO plans have been announced for Deep Blue Medical Advances.
How can I track Deep Blue Medical Advances secondary market activity?
Caplight tracks bids, offers, and trades in Deep Blue Medical Advances's shares on secondary markets.